BBLG Bone Biologics Corporation
Healthcare$1.26+3.28%ClosedMarket Cap: $2.3M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.47
P/S
0.00
EV/EBITDA
0.81
DCF Value
$4.22
FCF Yield
-117.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-50.4%
ROA
-57.4%
ROIC
-64.3%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | NaN% | $-805.1K | $-766.0K | $— | — |
| Q4 null | $0.00 | NaN% | $-733.1K | $-684.6K | $— | — |
| FY null | $0.00 | NaN% | $-3.2M | $-3.1M | $— | — |
| Q3 null | $0.00 | NaN% | $-715.3K | $-666.7K | $— | — |
| Q2 null | $0.00 | NaN% | $-748.1K | $-740.5K | $— | — |
| Q1 null | $0.00 | NaN% | $-1.0M | $-1.0M | $— | — |
| Q4 null | $0.00 | NaN% | $-1.6M | $-1.5M | $— | — |
| FY null | $0.00 | NaN% | $-4.2M | $-4.1M | $— | — |
| Q3 null | $0.00 | NaN% | $-951.0K | $-941.0K | $— | — |
| Q2 null | $0.00 | NaN% | $-809.7K | $-783.7K | $— | — |
| Q1 null | $0.00 | NaN% | $-903.5K | $-866.0K | $— | — |
| Q4 2023 | $0.00 | NaN% | $-1.2M | $-1.6M | $48.03 | — |